Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Banco Macro Outperforms Industry Average With 10.1% Ytd Gain

EditorVenkatesh Jartarkar
Published 10/16/2023, 01:28 PM
Updated 10/16/2023, 01:28 PM
© Reuters.

Argentine bank, Banco Macro (BMA), has seen a year-to-date (YTD) stock value increase of 10.1%, surpassing the Banks - Foreign industry average gain of 9.1%. This performance, coupled with the bank's high earnings quality and high return on invested capital, as highlighted by InvestingPro Tips, has earned BMA a Buy rating from the Zacks Rank system, according to data released on Monday.

The Zacks Rank system, which includes BMA among its 848 companies in the finance sector, ranks this sector as 13th out of 16 sectors. BMA's recent surge in quarter earnings estimates by 100.7% underscores positive analyst sentiment and a promising outlook for the bank. This outlook is further reinforced by InvestingPro's real-time metrics which show a market cap of 2980M USD and a P/E ratio of 14.09, indicating a solid financial standing.

In addition to these metrics, BMA's strong earnings have allowed it to continue dividend payments with a notable dividend yield of 28.3%, as per InvestingPro data. The stockholders are receiving high returns on book equity, making BMA an attractive investment proposition. The bank has also seen revenue growth of 48.35% in the last twelve months (LTM2023.Q2), with total revenue reaching 2646.69M USD, according to InvestingPro's real-time metrics.

In contrast, Assurant (NYSE:AIZ), operating in the Insurance - multi-line industry, managed to secure an 18.5% stock value increase YTD despite an overall decline of 3.7% in its industry. Over the past three months, AIZ's EPS estimate growth of 14.1% has also resulted in a Buy rating from Zacks.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

BMA, a prominent player in the bank industry, is trading at a low P/E ratio relative to near-term earnings growth, as per InvestingPro Tips. This, along with the fact that analysts anticipate sales growth in the current year, makes BMA a compelling choice for investors seeking robust returns. For more insights like these, check out the additional 16 tips on InvestingPro's platform.

Despite some volatility in the stock price movements, BMA's strong return over the last five years and a large price uptick over the last six months, as identified by InvestingPro Tips, underscore its potential for sustained growth. The bank's next earnings date is scheduled for 2023-11-22, a significant event that could further impact its stock performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.